GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TaiGen Biopharmaceuticals Holdings Ltd (ROCO:4157) » Definitions » Issuance of Stock

TaiGen Biopharmaceuticals Holdings (ROCO:4157) Issuance of Stock : NT$0.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is TaiGen Biopharmaceuticals Holdings Issuance of Stock?

TaiGen Biopharmaceuticals Holdings's Issuance of Stock for the three months ended in Dec. 2024 was NT$0.0 Mil.

TaiGen Biopharmaceuticals Holdings's Issuance of Stock for the trailing twelve months (TTM) ended in Dec. 2024 was NT$0.0 Mil.


TaiGen Biopharmaceuticals Holdings Issuance of Stock Historical Data

The historical data trend for TaiGen Biopharmaceuticals Holdings's Issuance of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TaiGen Biopharmaceuticals Holdings Issuance of Stock Chart

TaiGen Biopharmaceuticals Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Issuance of Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 - - - -

TaiGen Biopharmaceuticals Holdings Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Issuance of Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

TaiGen Biopharmaceuticals Holdings Issuance of Stock Calculation

A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Issuance of Stock for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TaiGen Biopharmaceuticals Holdings Issuance of Stock Related Terms

Thank you for viewing the detailed overview of TaiGen Biopharmaceuticals Holdings's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


TaiGen Biopharmaceuticals Holdings Business Description

Traded in Other Exchanges
N/A
Address
No. 138 Xinming Road, 7th Floor, Neihu District, Taipei, TWN, 114
TaiGen Biopharmaceuticals Holdings Ltd is mainly engaged in the research and development of new drugs, including the selection of drug candidates, pre-IND trials and clinical trials. Its operating segment includes development, research and sales of new drugs, and other.

TaiGen Biopharmaceuticals Holdings Headlines

No Headlines